Wells Fargo & Company KINIKSA PHARMACEUTICALS INTL Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Number of Shares
13,639
Previous 14,133
3.5%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%